BioCryst Announces Approval of ORLADEYO® (berotralstat) in Saudi Arabia
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Stay updated with breaking news from John Bluth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
BCRX earnings call for the period ending June 30, 2022.
RESEARCH TRIANGLE PARK, N.C., July 15, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
RESEARCH TRIANGLE PARK, N.C., June 09, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the company has entered...